Extracorporeal photopheresis with permanent subcutaneous right atrial catheters

J Dtsch Dermatol Ges. 2007 Dec;5(12):1112-8. doi: 10.1111/j.1610-0387.2007.06524.x. Epub 2007 Sep 21.
[Article in English, German]

Abstract

Background: Adequate peripheral venous access is crucial for successful extracorporeal photopheresis (ECP). As this approach is not always feasible in older patients and patients with graft-versus-host disease, central venous catheters play an increasing role in providing long-term vascular access for ECP.However, not all catheters are able to deliver the minimum flow rate of 7 ml/min for ECP.

Patients and methods: Eight different permanent subcutaneous right atrial catheters were connected in vitro to the UVAR-XTS photopheresis system and median flow rates were determined. In addition, in vivo flow rates of patients who received ECP, using either peripheral or central venous access, were determined.

Results: Hemodialysis catheters with an internal diameter of 2.0 or 1.5 x 3.5 mm and a length up to 48 cm provided in vitro flow rates of 27-28 ml/min, almost identical to a peripheral access needle. Central venous catheters with a length of over 90 cm reached flow rates below 7 ml/min and are impractical for ECP. The analysis of 308 ECP collection cycles with peripheral vascular access revealed an average flow rate of 31.5 +/- 6.4 ml/min. Only permanent subcutaneous right atrial catheters made for hemodialysis provided similar flow rates (Quinton PermCath Dual Lumen) (33.7 +/- 4.7 ml/min, n = 198).

Conclusions: Permanent subcutaneous hemodialysis catheters with a length of maximally 48 cm achieve optimal flow rates for ECP. They represent therefore the central venous access of choice in patients with inadequate peripheral vascular access.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Blood Flow Velocity
  • Catheters, Indwelling*
  • Equipment Design
  • Equipment Failure Analysis
  • Female
  • Graft vs Host Disease / drug therapy
  • Humans
  • Hydrostatic Pressure
  • In Vitro Techniques
  • Lymphoma, T-Cell, Cutaneous / drug therapy
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Photopheresis / instrumentation*
  • Retrospective Studies